The impact of indacaterol/glycopyrronium fixed-dose combination versus tiotropium monotherapy on lung function and treatment preference: a randomized crossover study – the FA...

by Kardos P, Hagedorn-Peinz I
Published 2017-12-01

Practical considerations when prescribing a long-acting muscarinic antagonist for patients with COPD

by D’Urzo AD, Kardos P, Wiseman R
Published 2018-04-01

Health status in patients with COPD treated with roflumilast: two large noninterventional real-life studies: DINO and DACOTA

by Kardos P, Mokros I, Sauer R, Vogelmeier CF
Published 2018-05-01

Randomized controlled trials and real-world observational studies in evaluating cardiovascular safety of inhaled bronchodilator therapy in COPD

by Kardos P, Worsley S, Singh D, Román-Rodríguez M, Newby DE, Müllerová H
Published 2016-11-01

Omalizumab versus ‘Usual Care’: Results from a Naturalistic Longitudinal Study in Routine Care

by Wittchen, Hans-Ulrich, Mühlig, Stephan, Klotsche, Jens, Kardos, P., Ritz, T., Riedel, Oliver
Published 2013

A year in the life of German patients with COPD: the DACCORD observational study

by Buhl R, Criée CP, Kardos P, Vogelmeier C, Lossi N, Mailänder C, Worth H
Published 2016-07-01

Dual bronchodilation vs triple therapy in the “real-life” COPD DACCORD study

by Buhl R, Criée C, Kardos P, Vogelmeier CF, Kostikas K, Lossi NS, Worth H
Published 2018-08-01

“Real-life” inhaled corticosteroid withdrawal in COPD: a subgroup analysis of DACCORD

by Vogelmeier C, Worth H, Buhl R, Criée C, Lossi NS, Mailänder C, Kardos P
Published 2017-02-01